Recent advances in pancreatic cancer: biology, treatment, and prevention
被引:79
|
作者:
Singh, Divya
论文数: 0引用数: 0
h-index: 0
机构:
CUNY City Coll, Dept Biol, New York, NY 10031 USACUNY City Coll, Dept Biol, New York, NY 10031 USA
Singh, Divya
[1
]
Upadhyay, Ghanshyam
论文数: 0引用数: 0
h-index: 0
机构:
CUNY City Coll, Dept Biol, New York, NY 10031 USACUNY City Coll, Dept Biol, New York, NY 10031 USA
Upadhyay, Ghanshyam
[1
]
Srivastava, Rakesh K.
论文数: 0引用数: 0
h-index: 0
机构:
Vet Adm Med Ctr, Kansas City, MO 64128 USACUNY City Coll, Dept Biol, New York, NY 10031 USA
Srivastava, Rakesh K.
[2
]
Shankar, Sharmila
论文数: 0引用数: 0
h-index: 0
机构:
Vet Adm Med Ctr, Kansas City, MO 64128 USA
Univ Missouri, Sch Med, Dept Pathol, Kansas City, MO 64108 USACUNY City Coll, Dept Biol, New York, NY 10031 USA
Shankar, Sharmila
[2
,3
]
机构:
[1] CUNY City Coll, Dept Biol, New York, NY 10031 USA
[2] Vet Adm Med Ctr, Kansas City, MO 64128 USA
[3] Univ Missouri, Sch Med, Dept Pathol, Kansas City, MO 64108 USA
Pancreatic cancer;
Cancer stem cell;
Signaling pathways;
Cancer prevention;
Natural Product;
PHASE-III TRIAL;
EPITHELIAL-MESENCHYMAL TRANSITION;
HEDGEHOG SIGNALING PATHWAY;
ENDOTHELIAL GROWTH-FACTOR;
COOPERATIVE-ONCOLOGY-GROUP;
CELL-CYCLE PROGRESSION;
DNA TOPOISOMERASE-II;
STEM-CELLS;
BENZYL ISOTHIOCYANATE;
INTRAEPITHELIAL NEOPLASIA;
D O I:
10.1016/j.bbcan.2015.04.003
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Pancreatic cancer (PC) is the fourth leading cause of cancer-related death in United States. Efforts have been made towards the development of the viable solution for its treatment with constrained accomplishment because of its complex biology. It is well established that pancreatic cancer stem cells (CSCs), albeit present in a little count, contribute incredibly to PC initiation, progression, and metastasis. Customary chemo and radiotherapeutic alternatives, however, expands general survival, the related side effects are the significant concern. Amid the most recent decade, our insight about molecular and cellular pathways involved in PC and role of CSCs in its progression has increased enormously. Presently the focus is to target CSCs. The herbal products have gained much consideration recently as they, usually, sensitize CSCs to chemotherapy and target molecular signaling involved in various tumors including PC. Some planned studies have indicated promising results proposing that examinations in this course have a lot to offer for the treatment of PC. Although preclinical studies uncovered the importance of herbal products in attenuating pancreatic carcinoma, limited studies have been conducted to evaluate their role in clinics. The present review provides a new insight to recent advances in pancreatic cancer biology, treatment and current status of herbal products in its anticipation. (C) 2015 Elsevier B.V. All rights reserved.
机构:
Univ Hosp St Polten, Dept Internal Med 1, Div Oncol, St Polten, Austria
Karl Landsteiner Univ Hlth Sci, Krems, Austria
Karl Landsteiner Inst Oncol & Nephrol, Dunant Pl 1, A-3100 St Polten, AustriaUniv Hosp St Polten, Dept Internal Med 1, Div Oncol, St Polten, Austria
机构:
The Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of MedicineThe Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of Medicine
Somala Mohammed
George Van Buren Ⅱ
论文数: 0引用数: 0
h-index: 0
机构:
The Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of MedicineThe Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of Medicine
George Van Buren Ⅱ
William E Fisher
论文数: 0引用数: 0
h-index: 0
机构:
The Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of MedicineThe Elkins Pancreas Center,Michael E DeBakey Department of Surgery,and Dan L Duncan Cancer Center,Baylor College of Medicine